UBS Maintains Neutral on Pediatrix Medical Group, Lowers Price Target to $16
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and lowers the price target from $18.5 to $16.
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and lowers the price target from $18.5 to $16.